Infrequent false positive [(18)F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques

por Ikonomovic, Milos D., Fantoni, Enrico R., Farrar, Gill, Salloway, Stephen
Publicado 2018

Machine Learning Classification Identifies Cerebellar Contributions to Early and Moderate Cognitive Decline in Alzheimer’s Disease

por Bruchhage, Muriel M. K., Correia, Stephen, Malloy, Paul, Salloway, Stephen, Deoni, Sean
Publicado 2020

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering

por Cummings, Jeffrey, Aisen, Paul, Lemere, Cynthia, Atri, Alireza, Sabbagh, Marwan, Salloway, Stephen
Publicado 2021

A highly feasible, reliable, and fully remote protocol for mobile app‐based cognitive assessment in cognitively healthy older adults

por Thompson, Louisa I., Harrington, Karra D., Roque, Nelson, Strenger, Jennifer, Correia, Stephen, Jones, Richard N., Salloway, Stephen, Sliwinski, Martin J.
Publicado 2022

Adding cognition to AT(N) models improves prediction of cognitive and functional decline

por O'Shea, Deirdre M., Thomas, Kelsey R., Asken, Breton, Lee, Athene K.W., Davis, Jennifer D., Malloy, Paul F., Salloway, Stephen P., Correia, Stephen
Publicado 2021

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

por Hansson, Oskar, Edelmayer, Rebecca M., Boxer, Adam L., Carrillo, Maria C., Mielke, Michelle M., Rabinovici, Gil D., Salloway, Stephen, Sperling, Reisa, Zetterberg, Henrik, Teunissen, Charlotte E.
Publicado 2022

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

por Bateman, Randall J, Aisen, Paul S, De Strooper, Bart, Fox, Nick C, Lemere, Cynthia A, Ringman, John M, Salloway, Stephen, Sperling, Reisa A, Windisch, Manfred, Xiong, Chengjie
Publicado 2011

TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease

por Salloway, Stephen, Lee, Elly, Papka, Michelle, Pain, Andrew, Oru, Ena, Ferguson, Margaret B., Wang, Hong, Case, Michael, Lu, Ming, Collins, Emily C, Brooks, Dawn A., Sims, John
Publicado 2023

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

por Salloway, Stephen, Chalkias, Spyros, Barkhof, Frederik, Burkett, Patrick, Barakos, Jerome, Purcell, Derk, Suhy, Joyce, Forrestal, Fiona, Tian, Ying, Umans, Kimberly, Wang, Guanfang, Singhal, Priya, Budd Haeberlein, Samantha, Smirnakis, Karen
Publicado 2021

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease

por Bateman, Randall J., Cummings, Jeffrey, Schobel, Scott, Salloway, Stephen, Vellas, Bruno, Boada, Mercè, Black, Sandra E., Blennow, Kaj, Fontoura, Paulo, Klein, Gregory, Assunção, Sheila Seleri, Smith, Janice, Doody, Rachelle S.
Publicado 2022

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease

por Shaw, Leslie M., Arias, Jalayne, Blennow, Kaj, Galasko, Douglas, Molinuevo, Jose Luis, Salloway, Stephen, Schindler, Suzanne, Carrillo, Maria C., Hendrix, James A., Ross, April, Illes, Judit, Ramus, Courtney, Fifer, Sheila
Publicado 2018

Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer’s disease after a 27-m...

por Alber, Jessica, Maruff, Paul, Santos, Cláudia Y., Ott, Brian R., Salloway, Stephen P., Yoo, Don C., Noto, Richard B., Thompson, Louisa I., Goldfarb, Danielle, Arthur, Edmund, Song, Alex, Snyder, Peter J.
Publicado 2020

Remote and in‐clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults

por Thompson, Louisa I., Kunicki, Zachary J., Emrani, Sheina, Strenger, Jennifer, De Vito, Alyssa N., Britton, Karysa J., Dion, Catherine, Harrington, Karra D., Roque, Nelson, Salloway, Stephen, Sliwinski, Martin J., Correia, Stephen, Jones, Richard N.
Publicado 2023

Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly

por Becker, J Alex, Hedden, Trey, Carmasin, Jeremy, Maye, Jacqueline, Rentz, Dorene M, Putcha, Deepti, Fischl, Bruce, Greve, Douglas N, Marshall, Gad A, Salloway, Stephen, Marks, Donald, Buckner, Randy L, Sperling, Reisa A, Johnson, Keith A
Publicado 2011

Advancing combination therapy for Alzheimer's disease

por Salloway, Stephen P., Sevingy, Jeff, Budur, Kumar, Pederson, Jan Torleif, DeMattos, Ronald B., Von Rosenstiel, Philipp, Paez, Antonio, Evans, Rebecca, Weber, Christopher J., Hendrix, James A., Worley, Susan, Bain, Lisa J., Carrillo, Maria C.
Publicado 2020

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

por Pontecorvo, Michael J., Devous Sr, Michael D., Navitsky, Michael, Lu, Ming, Salloway, Stephen, Schaerf, Frederick W., Jennings, Danna, Arora, Anupa K., McGeehan, Anne, Lim, Nathaniel C., Xiong, Hui, Joshi, Abhinay D., Siderowf, Andrew, Mintun, Mark A.
Publicado 2017

Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mil...

por Salloway, Stephen, Honigberg, Lee A., Cho, William, Ward, Michael, Friesenhahn, Michel, Brunstein, Flavia, Quartino, Angelica, Clayton, David, Mortensen, Deborah, Bittner, Tobias, Ho, Carole, Rabe, Christina, Schauer, Stephen P., Wildsmith, Kristin R., Fuji, Reina N., Suliman, Shehnaaz, Reiman, Eric M., Chen, Kewei, Paul, Robert
Publicado 2018

Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzhe...

por Lu, Ming, Pontecorvo, Michael J., Devous, Michael D., Arora, Anupa K., Galante, Nicholas, McGeehan, Anne, Devadanam, Catherine, Salloway, Stephen P., Doraiswamy, P. Murali, Curtis, Craig, Truocchio, Stephen P., Flitter, Matthew, Locascio, Tricia, Devine, Marybeth, Zimmer, Jennifer A., Fleisher, Adam S., Mintun, Mark A.
Publicado 2021

Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial

por Ngolab, Jennifer, Donohue, Michael, Belsha, Alison, Salazar, Jennifer, Cohen, Paula, Jaiswal, Sandhya, Tan, Veasna, Gessert, Devon, Korouri, Shaina, Aggarwal, Neelum T., Alber, Jessica, Johnson, Ken, Jicha, Gregory, van Dyck, Christopher, Lah, James, Salloway, Stephen, Sperling, Reisa A., Aisen, Paul S., Rafii, Michael S., Rissman, Robert A.
Publicado 2021

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

por Gonneaud, Julie, Baria, Alex T., Pichet Binette, Alexa, Gordon, Brian A., Chhatwal, Jasmeer P., Cruchaga, Carlos, Jucker, Mathias, Levin, Johannes, Salloway, Stephen, Farlow, Martin, Gauthier, Serge, Benzinger, Tammie L. S., Morris, John C., Bateman, Randall J., Breitner, John C. S., Poirier, Judes, Vachon-Presseau, Etienne, Villeneuve, Sylvia
Publicado 2021